Glaxo Smith Kline Plc v. Controller of Patents & Designs .
In short. The case involves Glaxo Smith Kline PLC and others (the petitioners) challenging the Controller of Patents & Designs' decision to deny their application for an Exclusive Marketing Right (EMR) under the Patents Act, 1970. The Supreme Court of India upheld the High Court's order that had set aside the Controller's earlier decision and remanded the matter for fresh consideration based on the law as it stood on May 3, 2002. The court emphasized the need for the Controller to consider the examiner's report and the implications of the amendments made to the Patents Act in 2005.
Facts
The petitioners filed for a patent on August 28, 1998, and subsequently applied for EMR on June 30, 2000. The Controller of Patents initially rejected their EMR application on May 3, 2002. Dissatisfied, the petitioners filed two writ petitions in the Calcutta High Court, which led to the High Court setting aside the Controller's decision and ordering a fresh review. However, after the Controller again rejected the EMR application on December 28, 2004, the petitioners filed another writ petition on June 9, 2005. The legal landscape changed with the Patent (Amendment) Act, 2005, which deleted the provisions for EMR, leading to a dispute over the maintainability of the writ petition.
Arguments
Petitioner Arguments
The petitioners argued that the Controller's rejection of their EMR application was unjustified and that the High Court's order for a fresh review was warranted. They contended that the amendments to the Patents Act should not affect their pending application for EMR, as it was filed before the amendments took effect. The court addressed these arguments by emphasizing the need to consider the law as it existed at the time of the application and the examiner's report, thus validating the petitioners' position.
Respondent Arguments
The respondents, including the Controller of Patents and the Union of India, argued that the amendments to the Patents Act, which deleted the provisions for EMR, rendered the petitioners' application moot. They contended that any pending applications for EMR should be treated as requests for patent examination under the new provisions. The court critically examined this argument, ultimately finding that the petitioners' rights should be considered based on the law applicable at the time of their application.
Precedents considered
The judgment did not explicitly cite prior case law but relied on the legal principles established under the Patents Act, particularly regarding the treatment of applications for EMR and the implications of legislative amendments on pending applications.
Legal principles
The court considered the legal principle that pending applications should be adjudicated based on the law in effect at the time of filing. The deletion of Chapter IV-A of the Patents Act raised questions about the fate of pending EMR applications, which the court addressed by affirming the need for a fresh review by the Controller.
Decision and reasoning
Rationale
The court's rationale centered on the importance of adhering to the legal framework that existed when the petitioners filed their application. It highlighted the necessity for the Controller to consider the examiner's report and the implications of the amendments to ensure a fair adjudication process. The court was critical of the respondents' position that the amendments rendered the application moot, emphasizing the need for due process.
Outcome
The Supreme Court upheld the High Court's order, remanding the matter to the Controller of Patents for a fresh decision on the EMR application, taking into account the law as it stood on May 3, 2002, and the examiner's report. The court did not provide specific instructions regarding the appeal process, focusing instead on the need for a fair review.
Conclusion
This judgment underscores the significance of procedural fairness in patent law and the impact of legislative changes on pending applications. It reinforces the principle that applicants' rights should be evaluated based on the law in effect at the time of their application, ensuring that due process is upheld in patent adjudications.
Read the full judgment on the Supreme Court website (PDF)
Find the judgments that followed or distinguished it, with the paragraph relied on in each. Two answers free on WhatsApp, no signup.